EC
MD icon

EntryPoint Capital’s Pediatrix Medical MD Stock Holding History

EntryPoint Capital’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-26,109
Closed -$197K – 1058
2024
Q2 		$197K Buy
26,109
+21,099
+421% +$175K 0.09% 414
2024
Q1 		$50.3K Sell
5,010
-3,184
-39% -$29.6K 0.05% 763
2023
Q4 		$76.2K Buy
+8,194
New +$84.8K 0.07% 521

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

EntryPoint Capital's MD Position: Q3 2024 in Review

EntryPoint Capital sold out of Pediatrix Medical (MD) in Q3 2024, closing a stake of 26,109 shares — an estimated $197K sold.

EntryPoint Capital first reported a position in MD in Q4 2023 and held it in 3 quarters. The position peaked at $197K in Q2 2024. 218 funds tracked by Wall St. Rank hold MD as of Q3 2024.

  • EntryPoint Capital reported no remaining Pediatrix Medical position as of Q3 2024 after selling out during the quarter.
  • EntryPoint Capital sold 26,109 Pediatrix Medical shares in Q3 2024, an estimated $197K.
  • EntryPoint Capital first reported a position in Pediatrix Medical in Q4 2023 and held it in 3 quarters.
  • EntryPoint Capital's Pediatrix Medical position peaked at $197K in Q2 2024.
  • 218 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2024.

Based on EntryPoint Capital's 13F filing for Q3 2024, filed 13 Nov 2024.